SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-035673
Filing Date
2019-07-24
Accepted
2019-07-24 07:30:28
Documents
4
Period of Report
2019-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv525752_8k.htm 8-K 22714
2 EXHIBIT 1.1 tv525752_ex1-1.htm EX-1.1 228598
3 EXHIBIT 5.1 tv525752_ex5-1.htm EX-5.1 8676
4 GRAPHIC tv525752_logo.jpg GRAPHIC 3819
  Complete submission text file 0001144204-19-035673.txt   266522
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 19969223
SIC: 2834 Pharmaceutical Preparations